Lithotritie stéréotaxique. Système de localisation "Freeline". Un système sans contrainte pour garantir le traitement le plus efficace. Disponible sur toute la gamme Sonolith®.
Focal One® répond à tous les critères pour une thérapie focale idéale : fusion d'images IRM, approche chirurgicale non-invasive, énergie thérapeutique précise et efficace et validation de la zone traitée par IRM le lendemain du traitement.
EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it has received reimbursement approval in Switzerland for the use of High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer. This reimbursement took effect on July 1, 2023.
Read more
Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU) Platform for the Management of Prostate Cancer
Read more
EDAP TMS SA, a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT).
Read more
EDAP TMS SA, a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter and full-year 2022
Read more
EDAP TMS, un des leaders mondiaux sur la lithotritie extracorporelle, propose une gamme complète de solutions non-invasives et mini-invasives qui couvre toute l'étendue des indications du calcul urinaire.
EDAP TMS propose une alternative aux thérapies radicales standard telles que la chirurgie ou la radiothérapie, non-invasive et basée sur les ultrasons focalisés ...